Ecoslops S.A. (EPA:ALESA)

G1 Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.03	3.2	6.85	6.32	7.94
Short-Term Investments	3.57	0.01	0.02	0.02	0.01
Cash & Short-Term Investments	6.59	3.2	6.87	6.34	7.96
Cash Growth	105.71%	-53.36%	8.36%	-20.30%	33.05%
Accounts Receivable	1.19	1.64	4.05	5.09	0.49
Other Receivables	0.73	1.1	1.7	1.7	2.8
Receivables	1.91	2.73	5.75	6.79	3.28
Inventory	2.4	1.62	1.31	1.51	1.39
Prepaid Expenses	0.61	0.29	0.21	0.24	0.12
Other Current Assets	0.01	0.01	0.01	0.02	0.01
Total Current Assets	13.22	9.31	15.68	16.24	12.76
Property, Plant & Equipment	12.04	12.05	33.18	34.34	32.81
Long-Term Investments	0.22	0.62	0.62	0.02	0.02
Other Intangible Assets	0.52	0.65	0.79	0.92	1.05
Long-Term Deferred Charges	0.38	0.6	0.99	1.32	1.11
Other Long-Term Assets	0.3	10.65	-	-	-
Total Assets	26.85	34.07	51.42	53.01	47.91
Accounts Payable	1.44	1.97	3.99	4.11	2.91
Accrued Expenses	0.57	0.49	0.88	1.05	1.15
Short-Term Debt	0.01	-	0	0	0
Current Income Taxes Payable	-	0.02	0.15	-	-
Total Current Liabilities	2.02	2.48	5.02	5.16	4.07
Long-Term Debt	17.76	20.61	29.21	28.95	26.55
Long-Term Unearned Revenue	0.84	0.84	0.84	-	-
Long-Term Deferred Tax Liabilities	0.37	0.4	0.42	0.45	0.48
Other Long-Term Liabilities	0.83	2.29	0.33	0.28	0.41
Total Liabilities	21.81	26.61	35.82	34.85	31.51
Common Stock	5.19	5.19	5.18	5.16	4.44
Additional Paid-In Capital	38.59	38.59	38.59	38.61	33.21
Retained Earnings	-3.1	-7.35	-1.79	-3.72	-5.07
Comprehensive Income & Other	-35.64	-28.19	-26.3	-22.49	-17.32
Total Common Equity	5.04	8.24	15.68	17.57	15.26
Minority Interest	-	-0.78	-0.08	0.59	1.13
Shareholders' Equity	5.04	7.46	15.6	18.16	16.4
Total Liabilities & Equity	26.85	34.07	51.42	53.01	47.91
Total Debt	17.77	20.61	29.21	28.95	26.55
Net Cash (Debt)	-11.18	-17.4	-22.34	-22.61	-18.6
Net Cash Per Share	-2.16	-3.36	-4.36	-4.38	-4.18
Filing Date Shares Outstanding	5.18	5.18	5.18	5.16	4.43
Total Common Shares Outstanding	5.18	5.18	5.18	5.16	4.43
Working Capital	11.21	6.83	10.67	11.08	8.7
Book Value Per Share	0.97	1.59	3.03	3.41	3.44
Tangible Book Value	4.52	7.59	14.9	16.65	14.22
Tangible Book Value Per Share	0.87	1.46	2.88	3.23	3.21
Construction In Progress	0.46	0.42	0.26	0.08	18.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.